Folic acid plays a dual role in breast cancer depending on dose and context. While moderate intake may reduce risk, high ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Dr. Longwei Liu, a research assistant professor from the Mann Department of Biomedical Engineering and one of the study’s ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

But the new study showed that when certain genes are changed, these killer T cells can malfunction. Instead of protecting the ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.